MoonLake Immunotherapeutics
NASDAQ:MLTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MoonLake Immunotherapeutics
NASDAQ:MLTX
|
CH |
|
Infratil Ltd
NZX:IFT
|
NZ |
|
Mediclinic International PLC
LSE:MDC
|
UK |
|
A
|
Aaron Industries Ltd
NSE:AARON
|
IN |
|
Medistim ASA
OSE:MEDI
|
NO |
|
M
|
Metals Acquisition Ltd
ASX:MAC
|
JE |
|
OSG Corp
TSE:6136
|
JP |
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
IN |
Wall Street
Price Targets
MLTX Price Targets Summary
MoonLake Immunotherapeutics
According to Wall Street analysts, the average 1-year price target for MLTX is 30.19 USD with a low forecast of 6.06 USD and a high forecast of 73.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MLTX's stock price target?
Price Target
30.19
USD
According to Wall Street analysts, the average 1-year price target for MLTX is 30.19 USD with a low forecast of 6.06 USD and a high forecast of 73.5 USD.